Planning Strategies’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.36K Hold
8
– – ﹤0.01% 587
2026
Q2
$1.81K Buy
+8
New +$1.42K ﹤0.01% 614

Other funds holding CRL

Planning Strategies's CRL Position: Q3 2026 in Review

Planning Strategies held its Charles River Laboratories (CRL) position steady in Q3 2026 at 8 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Planning Strategies first reported a position in CRL in Q2 2026 and has held it in 2 quarters since. 642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Planning Strategies held 8 shares of Charles River Laboratories worth $2.36K as of Q3 2026.
  • Planning Strategies left its Charles River Laboratories share count unchanged in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #587 holding.
  • Planning Strategies first reported a position in Charles River Laboratories in Q2 2026 and has held it in 2 quarters since.
  • 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.